3-aminobenzamide has been researched along with Arterial Obstructive Diseases in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " The specific PARP inhibitor 3-aminobenzamide was injected 10 min before induction of ischemia at a dosage of 5, 10, and 20 mg/kg intracerebroventricularly." | 1.31 | The neuroprotective effect of cerebral poly(ADP-ribose)polymerase inhibition in a rat model of global ischemia. ( Bardenheuer, HJ; Kopitz, J; Martin, E; Plaschke, K; Weigand, MA, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Plaschke, K | 1 |
| Kopitz, J | 1 |
| Weigand, MA | 1 |
| Martin, E | 1 |
| Bardenheuer, HJ | 1 |
1 other study available for 3-aminobenzamide and Arterial Obstructive Diseases
| Article | Year |
|---|---|
The neuroprotective effect of cerebral poly(ADP-ribose)polymerase inhibition in a rat model of global ischemia.
Topics: Animals; Arterial Occlusive Diseases; Benzamides; Brain Ischemia; Carotid Artery, Common; Cerebral C | 2000 |